In our in vivo study, mice treated with a specific cPLA2 inhibitor, AACOCF3, had significantly smaller tumor burden compared to untreated controls; this suggests that a higher level of cPLA2 may play an important role in ovarian tumorigenesis. The gene discussed is PLA2G4A; the disease is neoplasm.